Admission to Trading
Oxford Biomedica PLC has announced the admission to trading of 92,381 ordinary shares of 50p each on the London Stock Exchange's Main Market. These new shares, which are fungible with existing shares, were allotted under the company's Long Term Incentive Plan, Sharesave Scheme, and Employee Share Option Scheme between January 21, 2026, and March 2, 2026. Following this admission, the total number of ordinary shares in issue for Oxford Biomedica PLC is now 120,873,439.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, OXB notifies the market that the following shares have been admitted to trading pursuant to their allotment under the OXB Long Term Incentive Plan (LTIP), OXB Sharesave Scheme (SAYE), OXB Employee Share Option Scheme (ESOS) as follows:
| Issuer name: | OXFORD BIOMEDICA PLC |
|---|---|
| Issuer LEI: | 213800S1GVQNXQ15K851 |
| Name, type and ISIN of the shares: | Ordinary shares of 50p each GB00BDFBVT43 |
| Number of further shares admitted to trading covered by the notification: | 92,381 |
| Total number of shares admitted to trading (including the new shares): | 120,873,439 |
| Date range covered by the notification: | 21 January 2026 - 02 March 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.